Western Alliance Bancorporation (NYSE:WAL – Get Free Report) announced a quarterly dividend on Monday, November 4th, Wall Street Journal reports. Investors of record on Friday, November 15th will be given a dividend of 0.38 per share by the financial services provider on Friday, November 29th. This represents a $1.52 annualized dividend and a dividend yield of 1.84%. The ex-dividend date is Friday, November 15th. This is an increase from Western Alliance Bancorporation’s previous quarterly dividend of $0.37.
Western Alliance Bancorporation has increased its dividend by an average of 13.2% annually over the last three years. Western Alliance Bancorporation has a payout ratio of 16.5% meaning its dividend is sufficiently covered by earnings. Analysts expect Western Alliance Bancorporation to earn $8.91 per share next year, which means the company should continue to be able to cover its $1.48 annual dividend with an expected future payout ratio of 16.6%.
Western Alliance Bancorporation Stock Performance
Western Alliance Bancorporation stock traded down $0.71 on Monday, hitting $82.60. The company’s stock had a trading volume of 602,849 shares, compared to its average volume of 1,309,192. Western Alliance Bancorporation has a one year low of $43.20 and a one year high of $94.28. The company has a quick ratio of 0.85, a current ratio of 0.88 and a debt-to-equity ratio of 1.07. The firm has a market cap of $9.09 billion, a P/E ratio of 12.86, a price-to-earnings-growth ratio of 1.30 and a beta of 1.44. The company has a fifty day moving average price of $83.77 and a 200-day moving average price of $72.41.
Analyst Ratings Changes
View Our Latest Analysis on WAL
Insiders Place Their Bets
In other Western Alliance Bancorporation news, insider Barbara Kennedy sold 11,083 shares of Western Alliance Bancorporation stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $81.59, for a total value of $904,261.97. Following the transaction, the insider now owns 7,977 shares of the company’s stock, valued at approximately $650,843.43. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In other news, Director Robert P. Latta sold 2,996 shares of the company’s stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $82.75, for a total value of $247,919.00. Following the sale, the director now directly owns 4,056 shares of the company’s stock, valued at approximately $335,634. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Barbara Kennedy sold 11,083 shares of Western Alliance Bancorporation stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $81.59, for a total value of $904,261.97. Following the transaction, the insider now owns 7,977 shares of the company’s stock, valued at $650,843.43. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 2.75% of the company’s stock.
About Western Alliance Bancorporation
Western Alliance Bancorporation operates as the bank holding company for Western Alliance Bank that provides various banking products and related services primarily in Arizona, California, and Nevada. It operates through Commercial and Consumer Related segments. The company offers deposit products, including checking, savings, and money market accounts, as well as fixed-rate and fixed maturity certificates of deposit accounts; demand deposits; and treasury management and residential mortgage products and services.
Recommended Stories
- Five stocks we like better than Western Alliance Bancorporation
- What Investors Need to Know About Upcoming IPOs
- Intel: Is Now the Time to Be Brave?
- How to Invest in Insurance Companies: A Guide
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Western Alliance Bancorporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Western Alliance Bancorporation and related companies with MarketBeat.com's FREE daily email newsletter.